Hyponatremic with cerebral convulsions: Complications of a treatment of enuresis nocturna with desmopressin;Hyponatriamie mit zerebralem krampfanfall: Komplikation einer behandlung mit desmopressin bei enuresis nocturna

Monatsschrift fur Kinderheilkunde

Volumn 148, Issue 8, 2000, Pages 768-770

  Frolich J ^a   Wiater, A ^a  

^a Krankenhaus Porz am Rhein   (Germany)

Author keywords

Cerebral convulsions; Desmopressin; Enuresis nocturna; Hyponatriemia

Indexed keywords

DESMOPRESSIN; ELECTROLYTE; SODIUM;

ARTICLE; CASE REPORT; CHILD; CONVULSION; ELECTROENCEPHALOGRAPHY; HUMAN; HYPONATREMIA; MALE; NOCTURNAL ENURESIS;

EID: 0033865445     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050636     Document Type: Article

References (40)

1. Antidepressant treatments in children and adolescents: II. Anxiety, physical and behavioral disorders
2. Dangers of intranasal desmopressin for nocturnal enuresis
3. Hyponatremic seizures in a child treated with desmopressin to control enuresis
4. Desmopressin in the management of nocturnal enuresis in children: A double blind study
5. Desmopressin as treatment for enuresis
6. Hyponatriemic seizure in a child using desmopressin for nocturnal enuresis
7. Nocturnal enuresis in childhood
8. Desmopressin for bedwetting: Length of treatment, vasopressin secretion, and response
9. Factors related to the age of attainment of nocturnal bladder control: An 8-year longitudinal study
10. Pharmacological and behavioral management of enuresis
11. Childhood enuresis: Prevalence, perceived impact and prescribed treatments
12. Micturition habits and incontinence in 7-year old Swedish school infants
13. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe
14. Pharmacological treatment of bedwetting
15. Aetiological and precipitating factors for childhood enuresis
16. Low-dose DDAVP in nocturnal enuresis
17. Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP)
18. Reference values for renal concentrating capacity in children by the desmopressin test
19. Urine concentration and enuresis in healthy preschool children
20. Desmopressin acetate and nocturnal enuresis: How much do we know?
21. Symptomatic hyponatriemia secondary to DDAVP treatment for primary enuresis
22. Diurnal antidiuretic-hormone-levels in enuretics
23. Urinary levels of antidiuretic hormone in nocturnal enuresis
24. Severe hyponatremia after administration of demopressin
25. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis
26. Hyponatremia in patients with nocturnal enuresis treated with DDAVP
27. Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing
28. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis
29. Convulsion and coma after intranasal DDAVP in cystic fibrosis
30. Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis
31. Desmopressin in nocturnal enuresis
32. Management of nocturnal enuresis with a vasopressin analogue
33. Functional enuresis: Is desmopressin the answer?
34. Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus
35. Basic pharmacology of desmopressin. A review
36. Primary norcurnal enuresis: Current concepts about an old problem
37. Comparison of desmopressin and enuresis alarm for nocturnal enuresis
38. Intranasal desmopressin-induced hyponatremia
39. Aminoacids and peptides LXXI. Synthesis of 1-desamino-8-D-Amino-butyrine vasopressin, 1-desamino-8-D-lysine vasopressin and 1-desamino-8-D-arginine vasopressin